These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36757880)

  • 1. Summary of the clinical practice manual for late-onset hypogonadism.
    Ide H; Akehi Y; Fukuhara S; Ohira S; Ogawa S; Kataoka T; Kumagai H; Kobayashi K; Komiya A; Shigehara K; Syuto T; Soh J; Tanabe M; Taniguchi H; Chiba K; Matsushita K; Mitsui Y; Yoneyama T; Shirakawa T; Fujii Y; Kumano H; Ueshiba H; Amano T; Sasaki H; Maeda S; Mizokami A; Suzuki K; Horie S
    Int J Urol; 2023 May; 30(5):422-430. PubMed ID: 36757880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Testosterone the "Fountain of Youth" for Aging Men?
    Giagulli VA; Lisco G; Mariano F; De Tullio A; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2023; 23(2):169-178. PubMed ID: 35578868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile dysfunction and hypogonadism (low testosterone).
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():2-7. PubMed ID: 21501544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.
    Hellstrom WJ; Paduch D; Donatucci CF
    Int Urol Nephrol; 2012 Feb; 44(1):61-70. PubMed ID: 21152980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The "obese" and "old" male patient in dermatological practice. When should hypogonadism be considered?].
    Varwig-Janßen D; Ochsendorf F
    Hautarzt; 2015 Dec; 66(12):898-906. PubMed ID: 26541589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An idiopathic hypogonadotropic hypogonadism patient with metabolic disorder and diabetes: case report.
    Zhang MN; Su B; Qian CH; Bu L; Cheng XY; Li WJ; Qu S
    Asian J Androl; 2015; 17(2):341-2. PubMed ID: 25337838
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men.
    Corona G; Bianchini S; Sforza A; Vignozzi L; Maggi M
    Hormones (Athens); 2015; 14(4):569-78. PubMed ID: 26732155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male.
    Ahmed K; Hatzimouratidis K; Muneer A
    Eur Urol Focus; 2017 Oct; 3(4-5):514-516. PubMed ID: 29331623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadism in men: Updates and treatments.
    Ugo-Neff G; Rizzolo D
    JAAPA; 2022 May; 35(5):28-34. PubMed ID: 35421871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
    Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
    Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.
    Conners WP; Morgentaler A
    Curr Urol Rep; 2013 Dec; 14(6):557-64. PubMed ID: 23999611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LOH (late-onset hypogonadism].
    Itoh N; Hisasue S; Tsukamoto T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():499-503. PubMed ID: 16689357
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolving issues in male hypogonadism: evaluation, management, and related comorbidities.
    Miner MM; Sadovsky R
    Cleve Clin J Med; 2007 May; 74 Suppl 3():S38-46. PubMed ID: 17549824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andropause.
    Vance ML
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S90-2. PubMed ID: 12914733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.